Search results

Wall Street analysts forecast that Globe Life (GL) will report quarterly earnings of $3.67 per share in its upcoming release, pointing to a year-over-year increase of 12.2%. It is anticipated that

Lamb Weston Holdings, Inc. LW is likely to witness top-line growth when it reports fourth-quarter fiscal 2026 earnings on July 24. The Zacks Consensus Estimate for revenues is pegged at $1.7

Cracker Barrel Old Country Store, Inc. CBRL is taking decisive steps to strengthen its financial position and sharpen focus on the core business. It recently completed a sale-leaseback transaction

Tenable Holdings TENB has rebounded sharply, making valuation the key issue for investors. The stock’s strong move reflects improving fundamentals, but it also reduces the margin of safety.The

Adaptive Biotechnologies (ADPT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

For those looking to find strong Transportation stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Euroseas Ltd. (ESEA) been one of those stocks this

Wall Street analysts forecast that UDR (UDR) will report quarterly earnings of $0.63 per share in its upcoming release, pointing to a year-over-year decline of 1.6%. It is anticipated that

Wall Street analysts forecast that Welltower (WELL) will report quarterly earnings of $1.55 per share in its upcoming release, pointing to a year-over-year increase of 21.1%. It is anticipated

Wall Street analysts forecast that Ameris Bancorp (ABCB) will report quarterly earnings of $1.66 per share in its upcoming release, pointing to a year-over-year increase of 4.4%. It is anticipated

Nektar Therapeutics NKTR announced that it has initiated the first two registrational studies in the phase III ZENITH AD program, which is evaluating its pipeline candidate, rezpegaldesleukin

Whirlpool Corporation WHR is expected to witness declines in its top and bottom lines when it reports second-quarter 2026 results.The household appliance company’s quarterly revenues are pegged at

Agios Pharmaceuticals AGIO announced that it has discontinued the development of its investigational drug, tebapivat, for the treatment of patients with sickle cell disease (SCD) after phase II

Hasbro, Inc. HAS has a better growth story than it had earlier in the year, but the investment case is not one-sided. The company beat expectations, raised its fiscal 2026 outlook and has

Palo Alto Networks PANW is expanding its Observability platform with the acquisition of Embrace, a provider of Real User Monitoring (RUM), and the launch of Synthetics, a new monitoring solution

SmarFinancial (SMBK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one